Overall, our findings facilitate the understanding the pathogenesis of AD, implying the role of IRAK4 inhibitor in AD and offering potential new preventive and therapeutic strategy as well as the novel insights of new medications in treating AD. The gene discussed is IRAK4; the disease is Alzheimer disease.